Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Operating activities:
Net earnings	$ 6,753,395	$ 4,782,238
Adjustments:
Depreciation	609,933	546,619
Amortization	164,480	76,656
Stock-based compensation	99,838	97,652
Deferred income taxes	(33,116)	166,748
Distributions from affiliates	25,571	200
Equity in earnings of unconsolidated affiliates	(23,246)	(65,106)
Losses on assets	0	50,970
Changes in assets and liabilities (exclusive of acquisitions and dispositions):
Accounts receivable	(104,751)	(1,622,668)
Inventories	371,068	(1,976,738)
Accounts payable	(299,760)	343,014
Federal income taxes	(302,335)	262,195
Salaries, wages and related accruals	121,243	835,381
Other operating activities	156,201	123,202
Cash provided by operating activities	7,538,521	3,620,363
Investing activities:
Capital expenditures	(1,430,125)	(1,207,088)
Investment in and advances to affiliates	(246)	(193)
Sale of business	99,681	0
Disposition of plant and equipment	27,278	15,581
Acquisitions (net of cash acquired)	(3,549,764)	(1,346,608)
Purchases of investments	(563,770)	(394,141)
Proceeds from the sale of investments	439,348	554,898
Other investing activities	(9,595)	1,042
Cash used in investing activities	(4,987,193)	(2,376,509)
Financing activities:
Net change in short-term debt	(43,074)	44,831
Proceeds from issuance of long-term debt, net of discount	2,091,934	196,990
Repayment of long-term debt	(1,108,500)	0
Bond issuance costs	(13,138)	0
Proceeds from exercise of stock options	21,604	143,874
Payment of tax withholdings on certain stock-based compensation	(62,869)	(71,494)
Distributions to noncontrolling interests	(300,772)	(120,619)
Cash dividends	(404,150)	(366,606)
Acquisition of treasury stock	(2,359,971)	(1,773,848)
Proceeds from government incentives	275,000	0
Other financing activities	(21,085)	(7,993)
Cash used in financing activities	(1,925,021)	(1,954,865)
Effect of exchange rate changes on cash	(5,221)	1,720
Increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents	621,086	(709,291)
Cash and cash equivalents and restricted cash and cash equivalents - beginning of year	2,508,658	2,754,929
Cash and cash equivalents and restricted cash and cash equivalents - end of nine months	3,129,744	2,045,638
Non-cash investing activity:
Change in accrued plant and equipment purchases	$ (31,469)	$ 14,997